Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Apoptosi

    2026-04-18

    Harnessing the Annexin V-FITC/PI Apoptosis Assay Kit for Advanced Cell Death Analysis

    Principle and Setup: Decoding Apoptosis with Dual-Fluorescence

    The Annexin V-FITC/PI Apoptosis Assay Kit (SKU: K2003, APExBIO) leverages the biology of phosphatidylserine (PS) externalization and membrane integrity to provide a reliable, two-color fluorescence-based readout of apoptosis. Annexin V-FITC binds PS exposed on the outer plasma membrane—a hallmark of early apoptosis—while propidium iodide (PI) stains nuclear DNA in cells with compromised membranes, characteristic of late apoptosis or necrosis (source: product_spec).

    This dual-staining approach enables robust discrimination among viable (Annexin V-/PI-), early apoptotic (Annexin V+/PI-), and late apoptotic/necrotic cells (Annexin V+/PI+ or Annexin V-/PI+), facilitating nuanced assessment of cell death pathways in diverse research contexts (source: product_spec).

    Step-by-Step Workflow and Protocol Enhancements

    The Annexin V-FITC apoptosis kit is optimized for rapid, one-step staining, typically requiring only 10–20 minutes. Below is a streamlined workflow, with practical modifications for increased reproducibility and data quality.

    1. Cell Preparation: Harvest cells (adherent or suspension) gently to avoid inducing artificial PS externalization. Wash twice with cold PBS and resuspend in 1X Binding Buffer at 1–5 × 105 cells per 100 µL (workflow_recommendation).
    2. Staining: Add 5 µL Annexin V-FITC and 5 µL PI to each sample. Gently mix and incubate at room temperature (RT, ~20–25°C) for 10–15 minutes in the dark to prevent fluorochrome bleaching (source: product_spec).
    3. Data Acquisition: Analyze samples promptly by flow cytometry (FITC: Ex 488 nm/Em 530 nm; PI: Ex 535 nm/Em 617 nm) or fluorescence microscopy. Acquire at least 10,000 events per sample for robust statistical analysis (workflow_recommendation).

    Tip: For complex samples or high-throughput workflows, the kit is compatible with automated plate readers equipped with appropriate filters, further accelerating data collection (source: product_spec).

    Protocol Parameters

    • assay | 5 µL Annexin V-FITC per 100 µL cell suspension | universal | ensures optimal signal-to-noise ratio for early apoptosis detection | product_spec
    • assay | 5 µL PI per 100 µL cell suspension | universal | enables clear discrimination of late apoptotic/necrotic cells | product_spec
    • incubation time | 10–15 minutes at room temperature (20–25°C) | adherent and suspension cells | minimizes photobleaching and non-specific binding | product_spec
    • cell density | 1–5 × 105 cells per 100 µL | optimal for flow cytometry | prevents cell clumping and ensures uniform staining | workflow_recommendation

    Advanced Applications and Comparative Advantages

    The Annexin V-FITC/PI Apoptosis Assay Kit is widely adopted in oncology, immunology, infection biology, and regenerative medicine. In cancer research, its ability to resolve early versus late apoptotic events aids in evaluating chemoresistance and the efficacy of novel therapeutics (source: product_spec). For infection and wound healing studies—such as those modeling Pseudomonas aeruginosa-induced damage—the assay enables researchers to monitor host cell death kinetics and optimize anti-infective strategies (source: paper).

    Comparative Advantages:

    • Speed: The one-step, 10–20 minute protocol outpaces traditional TUNEL or caspase assays (source: product_spec).
    • Sensitivity: Detects early, reversible apoptosis via PS exposure prior to DNA fragmentation—a crucial edge for mechanistic studies and drug screening (source: product_spec).
    • Multiparametric Analysis: Seamlessly integrates with additional markers (e.g., CD antigens) for multiparameter flow cytometry, enabling deeper phenotypic analysis (workflow_recommendation).

    Key Innovation from the Reference Study

    The reference study by Chang Ni et al. (Materials Today Bio, 2025) introduces a synergetic nano-delivery system (Apt-pM@UCNPmSiO2-Cur-CAZ) targeting Pseudomonas aeruginosa infections and promoting wound healing. Critically, the research employs flow cytometry-based apoptosis assays—such as Annexin V-FITC/PI staining—to quantify host cell viability and apoptosis following bacterial challenge and nanoformulation treatment.

    Translation to Practical Assays:

    • Infection Modeling: Researchers can use the Annexin V-FITC apoptosis kit to monitor macrophage or keratinocyte fate in response to bacterial toxins, antibiotics, or photodynamic therapy, as demonstrated in the paper.
    • Therapeutic Screening: The rapid, quantitative readouts enable high-throughput comparison of different antimicrobial or wound-healing interventions for their cytoprotective effects.
    • Workflow Synergy: The one-step staining protocol is ideal for dynamic time-course studies, where rapid sampling and parallel processing are essential to capture transient apoptotic events.

    Troubleshooting and Optimization: Maximizing Assay Robustness

    Despite its simplicity, several technical challenges can affect apoptosis assay outcomes. Here are evidence-based troubleshooting tips:

    • High Background or False Positives: Ensure cells are handled gently—mechanical stress or over-trypsinization can induce PS exposure. Use calcium-containing binding buffer as supplied for specific annexin-v binding (source: product_spec).
    • Low Signal Intensity: Validate fluorimeter/flow cytometer settings and check expiration/storage of reagents. Always protect the kit from light and store at 2–8°C for up to 6 months for maximum stability (product_spec).
    • Clumped Cells or Inconsistent Staining: Filter cell suspensions through a 40 µm mesh before staining and use recommended cell densities for uniform results (workflow_recommendation).
    • Interference from Autofluorescence: Include unstained and single-color controls to accurately set compensation and gating parameters, especially when analyzing primary cells or tissue-derived samples (workflow_recommendation).

    For advanced troubleshooting strategies and enhancements—such as combining with mitochondrial potential or caspase activity assays—see this in-depth discussion (complement).

    Interlinking Related Resources: Building a Knowledge Network

    Future Outlook: From Mechanistic Cell Death to Translational Impact

    With the emergence of targeted nano-delivery systems and advanced antimicrobial strategies, the need for rapid, reliable cell death quantification is greater than ever. The Annexin V-FITC/PI Apoptosis Assay Kit stands ready to accelerate discoveries in both basic and applied settings. As illustrated by the reference study's use of apoptosis assays to validate host response to infection and therapy, these tools are pivotal for bridging mechanistic insight and preclinical translation (source: paper).

    Looking forward, integration with high-dimensional single-cell platforms and machine learning–based phenotyping will further enhance the power and precision of apoptosis assays. APExBIO’s commitment to robust assay performance and workflow flexibility ensures that researchers remain at the forefront of cell death pathway analysis, whether investigating cancer therapeutics or novel anti-infective agents.